TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+17.76%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$351M
AUM Growth
+$351M
(+44%)
Cap. Flow
+$99.6M
Cap. Flow
% of AUM
28.41%
Top 10 Holdings %
Top 10 Hldgs %
55.99%
Holding
72
New
20
Increased
10
Reduced
9
Closed
31
Top Buys
| 1 |
Biogen
BIIB
|
$24.2M |
| 2 |
Neurocrine Biosciences
NBIX
|
$20.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$20.7M |
| 4 |
GSK
GSK
|
$12.1M |
| 5 |
Eli Lilly
LLY
|
$11.5M |
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$13.5M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$11.5M |
| 3 |
Evolent Health
EVH
|
$9.98M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$9.71M |
| 5 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$7.08M |
Sector Composition
| 1 | Healthcare | 97.22% |
| 2 | Consumer Staples | 2.78% |
| 3 | Energy | 0% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
